Gladstone and Stanford in collaboration to develop iPS cells for cardiac therapies

November 02, 2009

Scientists at the Gladstone Institute of Cardiovascular Disease (GICD) and Stanford University School of Medicine will collaborate in a new consortium funded by the National Heart, Lung and Blood Institute (NHLBI) to develop stem cell and regenerative medicine therapies. GICD investigators, led by GICD Director Deepak Srivastava, MD, will collaborate with a Stanford team led by Robert Robbins, MD, professor and chair of cardiothoracic surgery, to investigate how to use induced pluripotent stem cells, or iPS cells, to repair damaged heart muscle.

"This is an exciting opportunity to work with the most talented investigators in the field to accelerate the application of this promising technology to real patient benefits," said Srivastava. Each research team will receive approximately $10 million dollars over 7 years as part of the larger NHLBI Progenitor Cell Biology Consortium, which will bring together researchers from the heart, lung, blood, and technology research fields.

"NHLBI is committed to stimulating stem cell research that will lead to the development of regenerative therapies for the treatment of heart, lung and blood diseases," said NHLBI director Elizabeth Nabel, MD, in a press release. "Important gaps remain in our understanding of stem and progenitor cells, and this consortium holds great promise to expand our knowledge and uncover therapeutic applications of great public impact."

iPS cells result from the "reprogramming" of adult cells into a cell closely resembling an embryonic stem cell. Like stem cells, they can develop into any cell type in the body. This exciting technology was developed by Gladstone investigator Shinya Yamanaka, MD, PhD. the 2009 Lasker Award Recipient for Biomedical Research.

The 17 multidisciplinary teams are organized into nine thematic research hubs. The research will be coordinated and administrated out of the University of Maryland-Baltimore.

While a stem cell can renew itself indefinitely or differentiate into an adult cell, a progenitor cell can only divide a limited number of times and is often more limited than a stem cell in the kinds of cells it can become. Given the potential of these cells for clinical applications, the goals of the consortium are to identify and characterize progenitor cell lines, direct the differentiation of stem and progenitor cells to desired cell fates, and develop new clinical strategies to address the unique challenges presented by the transplantation of these cells.

The joint Gladstone-Stanford project capitalizes on the synergy of Gladstone investigators expertise in guiding cardiac cell fate decisions and iPS technology, with the strengths of Stanford investigators in tissue engineering, use of large animals for pre-clinical trials and high-resolution imaging of cells placed into animal models for regenerative therapies. "This consortium brings together the leading scientists in this field in a large-scare coordinated effort that may be a 'Manhattan Project' of stem cell research," Robbins said. "The aim is to investigate and evaluate the potential of this for the major diseases of our time."
-end-
Additional members of the joint team include Benoit Bruneau, Bruce Conklin and Shinya Yamanaka (Gladstone) and Michael Longaker, Mark Kay and Joseph Wu (Stanford).

Deepak Srivastava's primary affiliation is with the Gladstone Institute of Cardiovascular Disease, where he is director and where his laboratory is located and all of his research is conducted. He is also a professor of medicine in the Departments of Pediatrics and Biochemistry and Biophysics at the University of California, San Francisco.

About the Gladstone Institutes


The J. David Gladstone Institutes, an independent, nonprofit biomedical research organization, affiliated with the University of California, San Francisco, is dedicated to the health and welfare of humankind through research into the causes and prevention of some of the world's most devastating diseases. Gladstone is comprised of the Gladstone Institute of Cardiovascular Disease, the Gladstone Institute of Virology and Immunology and the Gladstone Institute of Neurological Disease. More information can be found at www.gladstone.ucsf.edu.

Gladstone Institutes

Related Stem Cells Articles from Brightsurf:

SUTD researchers create heart cells from stem cells using 3D printing
SUTD researchers 3D printed a micro-scaled physical device to demonstrate a new level of control in the directed differentiation of stem cells, enhancing the production of cardiomyocytes.

More selective elimination of leukemia stem cells and blood stem cells
Hematopoietic stem cells from a healthy donor can help patients suffering from acute leukemia.

Computer simulations visualize how DNA is recognized to convert cells into stem cells
Researchers of the Hubrecht Institute (KNAW - The Netherlands) and the Max Planck Institute in Münster (Germany) have revealed how an essential protein helps to activate genomic DNA during the conversion of regular adult human cells into stem cells.

First events in stem cells becoming specialized cells needed for organ development
Cell biologists at the University of Toronto shed light on the very first step stem cells go through to turn into the specialized cells that make up organs.

Surprising research result: All immature cells can develop into stem cells
New sensational study conducted at the University of Copenhagen disproves traditional knowledge of stem cell development.

The development of brain stem cells into new nerve cells and why this can lead to cancer
Stem cells are true Jacks-of-all-trades of our bodies, as they can turn into the many different cell types of all organs.

Healthy blood stem cells have as many DNA mutations as leukemic cells
Researchers from the Princess Máxima Center for Pediatric Oncology have shown that the number of mutations in healthy and leukemic blood stem cells does not differ.

New method grows brain cells from stem cells quickly and efficiently
Researchers at Lund University in Sweden have developed a faster method to generate functional brain cells, called astrocytes, from embryonic stem cells.

NUS researchers confine mature cells to turn them into stem cells
Recent research led by Professor G.V. Shivashankar of the Mechanobiology Institute at the National University of Singapore and the FIRC Institute of Molecular Oncology in Italy, has revealed that mature cells can be reprogrammed into re-deployable stem cells without direct genetic modification -- by confining them to a defined geometric space for an extended period of time.

Researchers develop a new method for turning skin cells into pluripotent stem cells
Researchers at the University of Helsinki, Finland, and Karolinska Institutet, Sweden, have for the first time succeeded in converting human skin cells into pluripotent stem cells by activating the cell's own genes.

Read More: Stem Cells News and Stem Cells Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.